15 years of Nature Nanotechnology

On the occasion of the anniversary, we look back at 15 years of great nanoscience and nanotechology. 


  • Picture of authors

    20th October 2021, 3.15 pm BST. We celebrate 15 years of Nature Nanotechnology with a series of webinar with experts in research at the nanoscale. In this first webinar we are joined by Prof. Ben Feringa and Prof. Robert Langer. Please register for the correct date.

  • Webinars banner

    To celebrate the 15th anniversary of Nature Nanotechnology we are joined by experts in various areas of research at the nanoscale in a series of webinars running from 20th October to 1st December. register for each webinar individually.

  • conference image

    In this forum we shall explore with experts the most recent progress in the clean water production technologies suitable for small scale and decentralized applications, e.g. nanofiltration, solar evaporation and distillation, atmospheric water harvesting. We shall also discuss the innovation and policy challenges that need to be overcome for the successful implementations of such technologies.

  • banner

    Join Nature Nano and a number of experts to discuss exciting topics in nanotechnology.

    Coming up:

    Nature Nano Talks - Nanotechnology and Global Health - A panel discussion 21st April, 3 pm UK time

Nature Nanotechnology is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


  • While chimeric antigen receptor (CAR) T cell-based therapy has been approved for clinical use for certain types of blood cancers, it remains difficult to achieve precise spatiotemporal control of the elicited anti-tumour response. Here, the authors propose light-switchable CAR T cells that can be remotely activated by a nano-optogenetic approach, reducing unwanted side effects.

    • Nhung Thi Nguyen
    • Kai Huang
    • Yubin Zhou
  • Trivalent arsenic (AsIII) is a clinically approved treatment agent for patients with promyelocytic leukaemia, but cannot be used for other types of leukaemia due to its toxicity. Here the authors show that different patient-derived leukaemia cells express CD71 and design a ferritin-based nanoparticle for specific delivery of AsIII to these cells, demonstrating substantially improved efficacy towards different leukaemia types in animal models, with reduced side effects.

    • Changlong Wang
    • Wei Zhang
    • Ding Ma
  • Magnon-mediated angular-momentum flow in antiferromagnets may become a design element for energy-efficient, low-dissipation and high-speed spintronic devices. Here, terahertz emission measurements in magnetic multilayers unveil a superluminal-like magnon velocity of ~650 km s–1 in the antiferromagnetic insulator NiO at nanoscale distances.

    • Kyusup Lee
    • Dong-Kyu Lee
    • Hyunsoo Yang
  • Engineering the energy dispersion of polaritons in microcavities can yield intriguing effects such as the anomalous quantum Hall and Rashba effects. Now, different Berry curvature distributions of polariton bands are obtained in a strongly coupled organic–inorganic two-dimensional perovskite single-crystal microcavity and can be modified via temperature and magnetic field variation.

    • Laura Polimeno
    • Giovanni Lerario
    • Daniele Sanvitto
  • Nanoparticle-mediated photoporation is used to temporarily permeabilize cell membranes for intracellular delivery of macromolecules, but cell exposure to nanoparticles might cause cellular damage and hamper application of the technique to therapeutic cell engineering. Here the authors show that, under photothermal heating, nanofibre-embedded iron oxide nanoparticles can be used to deliver effector macromolecules to different types of cells, in a contactless manner, with no cellular toxicity or diminished therapeutic potency.

    • Ranhua Xiong
    • Dawei Hua
    • Kevin Braeckmans
  • We celebrate the fifteenth anniversary of Nature Nanotechnology by looking at how the journal topics have expanded throughout the years.

  • Almost all currently used vaccines against COVID-19 consist of either non-viral or viral nanoparticles. Here we attempt to understand the reasons behind the success of such advanced nanoscale vaccine technologies compared with clinically established conventional vaccines, and the lessons to be learnt from this potentially transformative development in the adoption and acceptance of nanotechnology for medicine.

    • Thomas Kisby
    • Açelya Yilmazer
    • Kostas Kostarelos
  • Sharing the step-by-step procedures necessary to fabricate nanostructures could optimize efforts to achieve reproducible devices.

    • Mohammad J. Bereyhi
    • Tobias J. Kippenberg
  • The FAIR principles provide compelling guidelines on how to achieve reusability of nanotechnology data.

  • The challenge of assessing the scope and magnitude of risk from nanomaterials is urgent for society and ignoring risks could be detrimental for development. This challenge is bigger than the individual capacities on each side of the Atlantic, but effective cross-Atlantic collaboration can solve essential riddles about the use of nanomaterials.

    • Janeck James Scott-Fordsmand
    • Mónica João de Barros Amorim
    • Christine Ogilvie Hendren
  • Research on nanoplastic has already provided some significant results but it has also exposed a large number of open questions.

When nanotechnology focuses on COVID-19

When nanotechnology focuses on COVID-19

In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research

Nature Careers